News

Latest News

ICYMI: Rubio Joins America Reports

U.S. Senator Marco Rubio (R-FL) joined America Reports to discuss President-elect Donald Trump’s historic victory, Democrats’ proclamation of “resistance,” and the failure of identity politics. See below for highlights and watch the full interview on YouTube and...

read more

Inauguration Ticket Information

Senator Rubio's office is pleased to be issuing a limited number of tickets to President-elect Donald Trump's inauguration ceremony, which will occur on January 20, 2025 at the West Front of the U.S. Capitol. Floridians interested in receiving tickets should fill out...

read more

ICYMI: Rubio Joins Hannity

U.S. Senator Marco Rubio (R-FL) joined Hannity to discuss President-elect Donald Trump’s historic victory. See below for highlights and watch the full interview on YouTube and Rumble. On the ongoing realignment among American voters: “The Republican Party now reflects...

read more

Rubio, Colleagues Introduce Legislation to Increase Supply of Infant Formula

May 16, 2022 | Press Releases

Washington, D.C. — U.S. Senator Marco Rubio (R-FL) and colleagues introduced the Urgently Feeding America’s Babies Act (S. 4226). The bill would direct the Biden Administration to invoke the Defense Production Act and establish a process to approve the sale of European-produced infant formulas to address the ongoing shortage. Representative Vern Buchanan (R-FL) has introduced companion legislation in the U.S. House of Representatives. 
 
Senators Maggie Hassan (D-NH), Rick Scott (R-FL), and Alex Padilla (D-CA) are original cosponsors.
 
“This crisis is putting the lives of America’s babies in jeopardy,” Rubio said. “We must increase the supply of infant formula as quickly as possible, and this legislation would provide the tools to do so. We cannot afford to wait any longer.” 
 
“No parent should struggle to get the formula that they need to feed their babies and keep them healthy and safe,” Hassan said. “This commonsense, bipartisan bill will help increase the availability of baby formula, and I urge my colleagues to pass this legislation quickly. I will also keep pushing manufacturers and the administration to increase supply as fast as possible.”
 
“The baby formula shortage is heartbreaking and infuriating. Families are having to travel far just to get food for their babies,” Scott said. “Moms and dads are already hurting from Biden’s inflation crisis and shortages of formula are a kick while they’re down. Just like with every issue this administration faces, they have no immediate solutions, but this urgent issue deserves urgent action. Our bill, the Urgently Feeding America’s Babies Act, will direct the Biden administration to take action NOW to bring European-approved baby formula to stock U.S. shelves. Families can’t wait any longer.”
 
“It’s unacceptable that families are struggling to find formula for their children,” Padilla said. “There is no time to waste —we must take action on creative solutions to support the safe and rapid increase in the production and availability of baby formula that families rely on.”
 
“As a grandfather to eight young children, I know firsthand that there is no greater concern than parents being able to feed their children,” Buchanan said. “With more than 40 percent of our country’s most popular infant formulas out of stock, we need to use every tool at our disposal to ramp up domestic production as quickly as possible to make sure babies are fed. I look forward to working with Senator Rubio on our legislation, which requires the administration to utilize the Defense Production Act to dramatically increase supply of infant formula and help bring peace of mind to millions of families across the country.”
 
Specifically, the Urgently Feeding America’s Babies Act would: 

  • Direct President Joe Biden to designate infant formula as a scarce and critical material under the Defense Production Act; and 
  • Direct the U.S. Food and Drug Administration to establish a waiver process to approve the sale of infant formulas that are currently approved for sale in the European Union and to publish safety guidelines for each product approved via waiver.  

 
Related: